Skip to content
Screener

AN2 Therapeutics, Inc. ANTX Q1 2025 earnings

Reported May 13, 2025 · Before market open

EPS-$0.35Miss by $0.09
EPS estimate-$0.26

Next report

Nov 5, 2026 (in 2 months)
EPS estimate-$0.20

FAQ

When did AN2 Therapeutics, Inc. report Q1 2025 earnings?
AN2 Therapeutics, Inc. (ANTX) reported Q1 2025 earnings on May 13, 2025 before market open.
What were AN2 Therapeutics, Inc.'s Q1 2025 revenue and EPS?
AN2 Therapeutics, Inc. reported eps of $-0.35 for Q1 2025.
Did AN2 Therapeutics, Inc. beat estimates in Q1 2025?
EPS missed the consensus estimate of $-0.26 by $0.09.
How did AN2 Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 37.5% from $-0.56.
Where can I find AN2 Therapeutics, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-070305) and the 10-Q periodic report (0000950170-25-070358) directly on SEC EDGAR. The filing index links above go to sec.gov.